Scientists have found that rare variants in the gene coding an enzyme that controls the activity of a key immune cell occur more frequently in individuals with autoimmune disorders like rheumatoid arthritis and type 1 diabetes. Their report identifies a pathway that could be a therapeutic target and may present a model for future investigations of the role of rare gene variants in common disorders.